Exicure (XCUR) Amortization of Deferred Charges (2016 - 2022)
Exicure (XCUR) reported Amortization of Deferred Charges of $477000.0 for Q1 2022, up 581.43% on a YoY basis from $70000.0 in Q1 2021, and up 571.83% quarter-over-quarter from $71000.0 in Q4 2021.
Exicure (XCUR) Amortization of Deferred Charges (2016 - 2022) Analysis & Trends
Exicure has reported Amortization of Deferred Charges for 7 years, with the latest figure at $477000.0 in Q1 2022.
- For the quarter ending Q1 2022, Amortization of Deferred Charges rose 581.43% year-over-year to $477000.0; the trailing twelve-month figure through Dec 2022 stood at $477000.0 (up 122.9% YoY), and the FY2022 full-year result was $477000.0, up 67.96% from the prior year.
- Amortization of Deferred Charges for Q1 2022 stood at $477000.0, up from $71000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $477000.0 in Q1 2022, with the low at $4000.0 in Q3 2020.
- Historically, Amortization of Deferred Charges has averaged $68125.0 across 5 years, with a median of $36500.0 in 2021.
- Annual changes were most pronounced in 2020 — Amortization of Deferred Charges slumped 92.45% — and 2021, when it surged 800.0%.
- Exicure's Amortization of Deferred Charges stood at $25000.0 in 2018, then surged by 112.0% to $53000.0 in 2019, then jumped by 35.85% to $72000.0 in 2020, then retreated by 1.39% to $71000.0 in 2021, then jumped by 571.83% to $477000.0 in 2022.
- The last three Amortization of Deferred Charges figures came in at $477000.0 (Q1 2022), $71000.0 (Q4 2021), and $36000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Exicure | 17.53 Mn | 14.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 477,000.00 |
| Mar 31, 2022 | 477,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 36,000.00 |
| Sep 30, 2021 | 36,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 70,000.00 |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 72,000.00 |
| Dec 31, 2020 | 72,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Dec 31, 2019 | 53,000.00 |
| Dec 31, 2019 | 53,000.00 |
| Sep 30, 2019 | 53,000.00 |
| Sep 30, 2019 | 53,000.00 |